bcg (bacillus calmette-guerin) moreau strain

Poland

Drugs containing this active substance

  • ONKO BCG 50

    The medicine is used in the treatment of superficial, non-invasive bladder tumors. It aims to destroy the tumor or prevent its recurrence by stimulating the immune system.

    Form: powder and solvent for preparation of suspension for intravesical administration

    Active substance Dosage
    bcg (bacillus calmette-guerin) moreau strain 50 mg (not less than 150 million live BCG bacilli)/ml

    ATC: L03AX03

    Manufacturer: Synthaverse S.A.